With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

Expert Systems, a hybrid AI enabled drug discovery and development accelerator, announced a significant milestone in a ...

ARTIFICIAL intelligence (AI) is at the forefront of modern medicine, offering solutions to long-standing challenges across diagnostics, treatment, and ...

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused ...

Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

Consumer Electronics Show CES the world premier tech show concluded in the US city of Las Vegas on Friday showcasing the latest advanc ...

The 2025 Consumer Electronics Show (CES), the world's premier tech show, concluded in the U.S. city of Las Vegas on Friday, ...

We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at ...

Francis deSouza is Google Cloud’s new chief operating officer. He co-founded AI research startup Synth Labs last year after ...

Moana and its sequel are two of the most successful movies in the history of Walt Disney Studios, and now, the company has been hit with a lawsuit claiming that the idea for both Moana and its sequel ...

Absci (NASDAQ:ABSI – Free Report) had its price objective cut by KeyCorp from $6.00 to $5.00 in a research note released on Wednesday,Benzinga reports. They currently have an overweight rating on the ...